Status:
COMPLETED
Influenza Resistance Information Study
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Influenza
Eligibility:
All Genders
Brief Summary
This study will assist in the early detection of influenza resistant to antivirals and will monitor the clinical outcome of adults and children infected with influenza according to subtype and suscept...
Eligibility Criteria
Inclusion
- Participants greater than or equal to (≥) 1 year of age with a positive diagnostic test of influenza and/or displaying symptoms suggestive of influenza-like illness (during Years 1 to 5)
- Participants less than or equal to (≤) 12 years of age with a positive diagnostic test of influenza and displaying symptoms suggestive of influenza-like illness and who are being or, according to local standard of care, will be treated with an influenza antiviral (during Years 6 and 7)
Exclusion
- Allergy to any potential influenza therapy
- Living in the same household or residential/care home as another study participant
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
4561 Patients enrolled
Trial Details
Trial ID
NCT00884117
Start Date
January 1 2009
End Date
November 1 2015
Last Update
October 19 2016
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Chicago, Illinois, United States, 60655
2
Westmead, New South Wales, Australia, 2145
3
Bron, France, 69677
4
Berlin, Germany, 14052